2020
DOI: 10.1530/eje-20-0566
|View full text |Cite
|
Sign up to set email alerts
|

Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease

Abstract: Objective: Iodide transport across thyrocytes constitutes a critical step for thyroid hormone biosynthesis, mediated mainly by the basolateral sodium-iodide-symporter (NIS) and the apical anion exchanger pendrin (PDS). Both transmembrane proteins have been described as autoantigens in thyroid disease, yet the reports on autoantibody (aAb) prevalence and diagnostic usefulness are conflicting. Reasons for the inconclusive findings may be small study groups and principle differences in the technologies used. Des… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
24
0
1

Year Published

2021
2021
2025
2025

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 21 publications
(27 citation statements)
references
References 41 publications
2
24
0
1
Order By: Relevance
“…Initially, strongly varying and particularly high prevalence has been reported in thyroid patients, partly due to the usage of small peptides as bait molecules in the aAb assays. Subsequent studies using full-length proteins either by radioactive ligand binding [46] or via detection of antigen-reporter fusion proteins [26] indicated a similar and moderate prevalence, and in a range compatible to what is reported in this manuscript for MCT8-aAb and MCT10-aAb, respectively. Longitudinal studies for elucidating a potential role of such aAb for thyroid disease incidence are consistently lacking, but it is not unlikely that transporter-targeting aAb to iodide or TH uptake are eliciting biological activity in human subjects.…”
Section: Discussionsupporting
confidence: 85%
“…Initially, strongly varying and particularly high prevalence has been reported in thyroid patients, partly due to the usage of small peptides as bait molecules in the aAb assays. Subsequent studies using full-length proteins either by radioactive ligand binding [46] or via detection of antigen-reporter fusion proteins [26] indicated a similar and moderate prevalence, and in a range compatible to what is reported in this manuscript for MCT8-aAb and MCT10-aAb, respectively. Longitudinal studies for elucidating a potential role of such aAb for thyroid disease incidence are consistently lacking, but it is not unlikely that transporter-targeting aAb to iodide or TH uptake are eliciting biological activity in human subjects.…”
Section: Discussionsupporting
confidence: 85%
“…Initially, strongly varying and particularly high prevalence has been reported in thyroid patients, partly due to the usage of small peptides as bait molecules in the aAb assays. Subsequent studies using full-length proteins either by radioactive ligand binding [39] or via detection of antigen-reporter fusion proteins [19] indicated a similar and moderate prevalence, and in a range compatible to what is reported in this manuscript for MCT8-aAb and MCT10-aAb, respectively. Longitudinal studies for elucidating a potential role of such aAb for thyroid disease incidence are consistently lacking, but it is not unlikely that transporter-targeting aAb to iodide or TH uptake are eliciting biological activity in human subjects.…”
Section: Discussionsupporting
confidence: 85%
“…The identification of MCT8-aAb and MCT10-ab is not very surprising, as there is an increasing number of well-characterized examples of clinically relevant aAb to endocrinerelevant membrane proteins. Besides the already mentioned TSH-receptor, also the thyroid transporters for iodide, i.e., the sodium-iodide symporter (NIS) and pendrin, have been described as potential autoantigens of the TH axis, and reliable test systems have been developed [19,39]. Initially, strongly varying and particularly high prevalence has been reported in thyroid patients, partly due to the usage of small peptides as bait molecules in the aAb assays.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations